Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

RVC awarded grant for new advanced medical imaging centre
The Vaccinology and Cell Therapy Hub (pictured) will be built as part of a £45 million redevelopment of the College's Potters Bar campus.

Centre will facilitate 'world-class' research, clinical work and training

The Royal Veterinary College (RVC) has received a £2.13 million Getting Building Fund grant towards building a new Cardiovascular Imaging Centre of Excellence (C-ICE) in Hertfordshire.

The new centre – funded by the Hertfordshire Local Enterprise Partnership (LEP) – will contain modern research and development facilities to help advance treatments for both humans and animals, as well as improving training for academics, students and veterinary sector enterprises.

According to the College, C-ICE will also contain a state-of-the-art 3 Tesla MRI scanner capable of producing high-resolution images of pathological conditions for diagnostic and treatment evaluation.

The scanner will be fully integrated with the RVC’s Queen Mother Hospital for Animals and will be used initially to research novel treatments in experimental animal models of human disease and then in veterinary patients – in particular, neurological and cardiac conditions.

The RVC aims to bolster Hertfordshire's strong biopharma sector through a £45 million redevelopment of it's Potters Bar campus. This will create improved teaching facilities and a new Veterinary Vaccinology and Cell Therapy Hub.

As part of this new science hub, C-ICE will also include a cardiac catheterisation lab, which the College states will facilitate the delivery of cell and gene therapies – also known as ‘living medicines’ - into the cardiac circulation through coronary artery catheterisation.

Jonathan Elliott, vice-principal for research and innovation at the RVC, said:“I am delighted that the RVC has been awarded this grant. The establishment of this centre will not only pave the way for innovation in the field of regenerative medicine, precisely tailored to the individual patient, it will also contribute to the growth of our local economy.

“At the RVC we recognise the importance of a collaborative ‘One Health’ approach to cutting edge science which benefits both veterinary and human medicine.

“This centre will facilitate research which could transform the treatment of some of the most important debilitating chronic diseases affecting today’s ageing society.”

Image (c) Royal Veterinary College.

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.